Navigating Challenges in the Implementation of Early Peanut Introduction Guidelines

Navigating Challenges in the Implementation of Early Peanut Introduction Guidelines Posted By:
...

In 2017, the National Institute of Allergy and Infectious Diseases (NIAID) released guidelines advocating for the early introduction of peanuts to infants as a preventive measure against peanut allergies. The recommendations were based on the 2015 Learning Early About Peanut Allergy (LEAP) study which demonstrated that early introduction of peanut products to high-risk infants as early as 4 to 6 months substantially reduced their risk of developing peanut allergy later in life. Although many allergists were already implementing early introduction recommendations before the official 2017 guidelines were published, there remain several major barriers to implementing the recommendations, from both a provider and caregiver perspective.  

The NIAID Addendum Guidelines for the Prevention of Peanut Allergy discussed introduction and/or possible testing strategies for infants at high risk of developing peanut allergy. Below is a table summarizing the Addendum Guidelines: 

Table: Summary of NIAID Addendum Guidelines for the Prevention of Peanut Allergy

A recent 2023 study by Samady and colleagues found that only about 13% of parents said they are aware of the new guidelines, and only about 58% of primary care providers are discussing them with parents or caregivers. Those who do discuss early introduction with their provider are more likely to introduce peanuts earlier, but nearly 75% are still waiting until their child is at least 6 months of age.   

Unfortunately, numerous barriers and challenges to implementing the guidelines remain. One such barrier is outdated practice recommendations. Other barriers include inconsistent recommendations and lack of awareness of who is considered high-risk. Many providers may struggle to identify an infant with severe vs moderate forms of atopic dermatitis/eczema, and therefore consider any infant with eczema to be high-risk. Time constraints at well-visit appointments is a challenge for many parents and doctors, and there is also the fear of reaction, with many parents delaying introduction because of this. Reassuring parents, or even offering supervised feedings in the office setting, can help relieve some of this anxiety and increase successful introduction. Further, the addendum guidelines also contain appendices to help provide parents with at-home introduction for low-risk infants.  

An additional challenge is when primary care providers who order serum-specific IgE testing are unfamiliar with the interpretation of these results. In addition, many primary care providers will order full serum IgE food panels, which is not clinically indicated and can lead to unnecessary avoidance of other foods. When in doubt, it’s best to refer to an allergist for further guidance. Double-blind, placebo-controlled oral food challenges remain the gold standard for diagnosis of food allergy, and oral food challenges are safely done in the allergy office under supervision for appropriate patients or in those where the diagnosis is in question. 


Share

Filed under: NPs & PAs , Allergy/Immunology

Related
HIV Prevention and Testing Is Not Bound By Age

HIV Prevention and Testing Is Not Bound By Age

In 2006, the CDC updated the HIV testing guidelines to recommend routine opt-out testing for people ...

Filed under: Infectious Diseases, Preventive Medicine, Public Health, NPs & PAs


Continue Reading
Phase III FLOW Trial Results Establishes Semaglutide’s Role in Treating T2D and CKD

Phase III FLOW Trial Results Establishes Semagluti ...

The highly anticipated results of the FLOW (Evaluate Renal Function with Semaglutide Once Weekly) tr ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading
A Major Change in Asthma Management – Is This the Beginning of the End for SABAs?

A Major Change in Asthma Management – Is This th ...

The most recent updated Global Initiative for Asthma (GINA) guidelines recommend that short-acting ...

Filed under: Preventive Medicine, Pulmonary Medicine, NPs & PAs, Allergy/Immunology


Continue Reading
Artificial Intelligence in Healthcare: Our Next Great Innovation, Part III - AIs Use in the Future of Healthcare

Artificial Intelligence in Healthcare: Our Next Gr ...

During the first and second posts on artificial intelligence (AI) and healthcare, I explored AI’s ...

Filed under: Neurology, Health Policy and Trends, Miscellaneous, NPs & PAs


Continue Reading
The Importance of Shared Decision-making in Obesity

The Importance of Shared Decision-making in Obesit ...

Many areas of healthcare are starting to talk about the importance of shared decision-making (SDM), ...

Filed under: Cardiometabolic, NPs & PAs


Continue Reading
Addressing ASCVD Risk in HIV: An Update to the DHHS HIV Guidelines

Addressing ASCVD Risk in HIV: An Update to the DHH ...

The incidence of atherosclerotic cardiovascular disease (ASCVD) is estimated to be twice as high in ...

Filed under: Infectious Diseases, Preventive Medicine, Public Health, Cardiometabolic, NPs & PAs


Continue Reading